Electromed Inc 's ROA from the fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Electromed Inc 's ROA in the fourth quarter of 2026?
Electromed Inc achieved a return on average assets (ROA) of 18.94 % in its fourth quarter of 2026, this is above ELMD's average return on assets of 7%.
Electromed Inc assets over the 12 months ending in its fourth quarter of 2026 are valued at $60 million

ROA has improved compared to 18.31% in the third quarter of 2026, due to net income growth.

However, within the Healthcare sector 50 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 262, from total ROA ranking in the third quarter of 2026 at 335.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Total Assets Change	33.48 %	13.39 %	3 %	10.15 %	-2.39 %
Y / Y Net Income Change	54.31 %	58.8 %	40.29 %	44.91 %	20.57 %
Net Income (TTM) in million	11	10	9	8	8
Return On Assets (TTM)	18.94 %	18.31 %	16.83 %	15.46 %	14.55 %
ELMD's Total Ranking	# 262	# 335	# 339	# 362	# 390
Total Assets (TTM) in million	72	59	54	54	54
Seq. Total Assets Change	20.75 %	10.54 %	0.35 %	-0.35 %	2.58 %
Seq. Net Income Change	13.25 %	8.76 %	29.26 %	-3.09 %	16.55 %

ELMD's 5 Years Annual ROA >> Back to ELMD Management Effectiveness >> Compare ELMD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 8
Sector	# 51
Overall	# 236

Return On Assets Statistics
High	Average	Low
19.39 %	7 %	-11.63 %
(Jun 30 2026)		(Mar 31 2014)

Financial Statements
Electromed Inc 's Assets	$ 72 million	ELMD's Balance sheet
Electromed Inc 's Income	$ 3 million	Quarterly ELMD's Income Statement
ELMD's Income by Division		See ELMD's Income by Division

Annual Return On Assets	(Jun 30 2026) FY 2026	(Jun 30 2025) FY 2025	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022
Y / Y Total Assets Change	33.48 %	3 %	14.03 %	10.74 %	11.47 %
Total Assets in million	72	54	52	46	41
Y / Y Net Income Change	49.94 %	46.35 %	62.67 %	37.35 %	-2.41 %
Net Income in million	11	8	5	3	2
Annual Return On Assets	15.74 %	14.01 %	9.86 %	6.91 %	5.57 %

ELMD's 5 Years Annual ROA >> Back to ELMD Management Effectiveness >> Compare ELMD ROA to its Competitors

Comment on ELMD's ROA in the fiscal year ending 2026

In the fiscal year 2026 ROA improved to 15.74 % compared to prior year, due to annual net income growth of 49.94 % to $11.30 million, while value of Electromed Inc 's overall assets grew just by 33.48 % to $71.82 million, compared to $71.82 a year before.

More Return On Assets Ratios
ELMD's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ELMD's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ELMD's Competitors
Subscribers only: Roa for Electromed Inc 's Suppliers
Subscribers only: Return On Assets for ELMD's Customers

You may also want to know
ELMD's Roi	ELMD's Inventory Turnover Ratio	ELMD's Growth Rates	ELMD's Dividend Comparisons
	ELMD's Profitability Ratios	ELMD's Asset Turnover Ratio	ELMD's Dividend Growth
ELMD's Roe	ELMD's Valuation Ratios	ELMD's Financial Strength Ratios	ELMD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Lensar Inc	47.48 %
Elite Pharmaceuticals Inc	46.11 %
Omeros Corporation	46.05 %
Q32 Bio Inc	45.18 %
Aurinia Pharmaceuticals Inc	44.95 %
Agenus Inc	44.86 %
Earth Science Tech Inc	44.02 %
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %

Date modified: 2026-09-08T15:22:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.